PPARGC1A and chronic kidney disease: A defect in fatty acid metabolism in both mouse and human CKD and in nephritic NZB/W mice has previously been associated with a decrease in expression of the master transcriptional regulator Pparγc1α that regulates mitochondrial biogenesis and fatty acid oxidation (Kang et al. 2015).